pharma · Bleeding Complication During Colon Polypectomy · Cancer of Colon
Yang Xiaotian
Yang Xiaotian is a pharma organization headquartered in CN. Primary therapeutic focus areas include Bleeding Complication During Colon Polypectomy, Cancer of Colon, Erosive Esophagitis, Gastric Cancer, Primary Aldosteron
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 5
- Drugs
- 2
- Patents
- 0
sequential combined AVS
Unknown · other · Primary Aldosteronism
sequential combined AVS for Primary Aldosteronism is a Unknown program (other) at Yang Xiaotian with 1 ClinicalTrials.gov record(s).
Internal code SCOPE PA
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Yang Xiaotian
- Phase
- Unknown
- Modality
- other
- Indication
- Primary Aldosteronism
- Status
- active
- Trials
- 1